Nicox teams up with Chinese firm to develop and sell glaucoma drug
PARIS (Reuters) – French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China. Glaucoma, which is damage to the optic nerve, is the second leading cause of blindness globally and is likely… Read More »